India Opens FDI To Pfizer Mumbai Firm, Defers Ahlcon Proposal
This article was originally published in PharmAsia News
Executive Summary
India has loosened its foreign direct investment restrictions to allow $387 million worth of new money in 19 China companies, one of them in Pfizer Limited (Mumbai).